Kurata, T., Nakaya, A., Yokoi, T., Niki, M., Kibata, K., Takeyasu, Y., . . . Nomura, S. (2017). Phase I/II study of erlotinib, carboplatin, pemetrexed, and bevacizumab in chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer harboring epidermal growth factor receptor mutation. Genes Cancer.
Citação norma ChicagoKurata, Takayasu, et al. "Phase I/II Study of Erlotinib, Carboplatin, Pemetrexed, and Bevacizumab in Chemotherapy-naïve Patients With Advanced Non-squamous Non-small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation." Genes Cancer 2017.
MLA citiranjeKurata, Takayasu, et al. "Phase I/II Study of Erlotinib, Carboplatin, Pemetrexed, and Bevacizumab in Chemotherapy-naïve Patients With Advanced Non-squamous Non-small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation." Genes Cancer 2017.